1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Epithelioid Sarcoma (ES): new trials by email Literature Review of Epithelioid Sarcoma (ES) trials Research Report on Epithelioid Sarcoma (ES)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study Tazemetostat - Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) | Phase 1 / Phase 2 | Terminated | Epizyme, Inc. | 58 | 2016-08-30 | 2026-10-28 |
Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Non-Hodgkin (1) · Mesothelioma (1) · Sarcoma (1) · Sarcoma, Synovial (1)
Adenoma (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Mesothelial (1)
tazemetostat (1)
Epizyme, Inc. (1)
Australia (1) · Belgium (1) · France (1) · Poland (1) · Ukraine (1) · United Kingdom (1) · United States (1)
2015 (1), 2023 (1)